Polo-like kinase-1 identified as a therapeutic target in RDEB CSCC Psoriasis skin = benign SCC = malignant 18 Oncogene. 2011 30(46):4666-77. PMID: 21602893 PMCID: PMC3219832 0 ONCONOVA THERAPEUTICS

View entire presentation